Novo Nordisk A/S (NYSE:NVO): A Strong Pipeline to Aid Recovery
We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on ValueInvestorsClub by cable888. In this article, we will ...
India's Sun Pharma aims to launch its obesity drug in five years, managing director says
India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...
Eucalyptus says weight loss drugs sales are booming
A steady supply of weight-loss drugs Wegovy and Mounjaro has helped lift Eucalyptus’ revenue from $78 million to $121 million ...
Sun Pharma aims to launch anti-obesity and type 2 diabetes drug Utreglutide in five years: Dilip Shanghvi
Sun Pharmaceutical, India's largest drugmaker by revenue, plans to launch its experimental anti-obesity and type 2 diabetes ...